Alector Inc (ALEC)
4.82
-0.43
(-8.19%)
USD |
NASDAQ |
Apr 25, 16:00
4.81
-0.01
(-0.21%)
After-Hours: 20:00
Alector Cash from Operations (TTM): -184.16M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -184.16M |
September 30, 2023 | -187.02M |
June 30, 2023 | -189.53M |
March 31, 2023 | -203.97M |
December 31, 2022 | -20.33M |
September 30, 2022 | -20.67M |
June 30, 2022 | 473.44M |
March 31, 2022 | 486.34M |
December 31, 2021 | 298.55M |
September 30, 2021 | 300.16M |
June 30, 2021 | -185.72M |
Date | Value |
---|---|
March 31, 2021 | -187.11M |
December 31, 2020 | -166.73M |
September 30, 2020 | -147.90M |
June 30, 2020 | -135.94M |
March 31, 2020 | -108.06M |
December 31, 2019 | -99.31M |
September 30, 2019 | -88.14M |
June 30, 2019 | -81.63M |
March 31, 2019 | -80.63M |
December 31, 2018 | 127.46M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-203.97M
Minimum
Mar 2023
486.34M
Maximum
Mar 2022
-23.56M
Average
-108.06M
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
AbbVie Inc | 22.84B |
Reviva Pharmaceuticals Holdings Inc | -28.32M |
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |